We are live on ! Find out more
IDYA icon

IDEAYA Biosciences

68 hedge funds and large institutions have $236M invested in IDEAYA Biosciences in 2020 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 26 increasing their positions, 14 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

86% more repeat investments, than reductions

Existing positions increased: 26 | Existing positions reduced: 14

33% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 12

6% more funds holding

Funds holding: 6468 (+4)

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

1.65% less ownership

Funds ownership: 68.24%66.59% (-1.6%)

10% less capital invested

Capital invested by funds: $262M → $236M (-$26.6M)

Holders
68
Holders Change
+4
Holders Change %
+6.25%
% of All Funds
1.37%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.04%
New
16
Increased
26
Reduced
14
Closed
12
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Bank of New York Mellon
26
Bank of New York Mellon
New York
$517K +$135K +10,885 +36%
Charles Schwab
27
Charles Schwab
California
$493K +$165K +13,285 +51%
Ensign Peak Advisors
28
Ensign Peak Advisors
Utah
$464K +$457K +36,915 New
California Public Employees Retirement System
29
California Public Employees Retirement System
California
$416K +$410K +33,100 New
Massachusetts Financial Services
30
Massachusetts Financial Services
Massachusetts
$374K +$369K +29,782 New
Dimensional Fund Advisors
31
Dimensional Fund Advisors
Texas
$353K +$350K +28,251 New
California State Teachers Retirement System (CalSTRS)
32
California State Teachers Retirement System (CalSTRS)
California
$303K +$73.9K +5,967 +33%
Acadian Asset Management
33
Acadian Asset Management
Massachusetts
$276K +$273K +22,076 New
AllianceBernstein
34
AllianceBernstein
Tennessee
$244K -$21.1K -1,700 -8%
State of Wisconsin Investment Board
35
State of Wisconsin Investment Board
Wisconsin
$244K +$240K +19,400 New
AC
36
Athanor Capital
New York
$230K +$37.1K +2,999 +20%
Susquehanna International Group
37
Susquehanna International Group
Pennsylvania
$213K +$210K +16,958 New
JP Morgan Chase
38
JP Morgan Chase
New York
$194K +$153K +12,349 +305%
Ameriprise
39
Ameriprise
Minnesota
$190K +$187K +15,110 New
RhumbLine Advisers
40
RhumbLine Advisers
Massachusetts
$172K +$4.01K +324 +2%
CSS
41
Cubist Systematic Strategies
Connecticut
$166K +$105K +8,482 +179%
Wells Fargo
42
Wells Fargo
California
$164K +$78.5K +6,338 +94%
TRCT
43
Tower Research Capital (TRC)
New York
$146K +$136K +10,994 +1,829%
New York State Common Retirement Fund
44
New York State Common Retirement Fund
New York
$138K
Goldman Sachs
45
Goldman Sachs
New York
$130K -$1.83M -147,931 -93%
AIG
46
American International Group
New York
$120K +$26.8K +2,167 +29%
Deutsche Bank
47
Deutsche Bank
Germany
$100K +$30.3K +2,447 +44%
Bank of America
48
Bank of America
North Carolina
$97K -$16.8K -1,359 -15%
Barclays
49
Barclays
United Kingdom
$91K +$8.03K +648 +10%
PAM
50
Panagora Asset Management
Massachusetts
$67K +$22K +1,780 +51%

IDYA Hedge Fund Activity: Q3 2020 in Review

68 of the 4,957 institutional investors tracked by Wall St. Rank reported a position in IDEAYA Biosciences (IDYA) for Q3 2020, worth a combined $236M — down 10% from $262M a quarter earlier.

Buyers outnumbered sellers: 16 funds opened new IDYA positions and 12 closed out — a net gain of 4 holders — while 26 added to existing stakes and 14 trimmed.

The largest buyer was DAFNA Capital Management, opening a new position worth an estimated $4.11M. The largest seller was Citadel Advisors, exiting entirely with an estimated $3.52M sold.

  • 68 institutional investors held IDEAYA Biosciences (IDYA) as of Q3 2020, up from 64 in Q2 2020.
  • Funds reported $236M of IDEAYA Biosciences stock for Q3 2020, down 10% quarter-over-quarter.
  • 16 funds opened new IDEAYA Biosciences positions in Q3 2020 and 12 closed out, a net change of +4 holders.
  • The largest IDEAYA Biosciences buyer in Q3 2020 was DAFNA Capital Management, an estimated $4.11M added.
  • The largest IDEAYA Biosciences seller in Q3 2020 was Citadel Advisors, an estimated $3.52M sold.

Based on aggregated 13F filings for Q3 2020.